Bio-Works today announces the launch of WorkBeads affimAb for purification of new biological pharmaceuticals on a large scale. As for all Bio-Works’ products, focus is on improved production efficiency. We aim to capture the target molecule (the pharmaceutical product) in the shortest possible time and to achieve a purification process that is as efficient as […]

Royalty bearing license agreement to commercialise a product incorporating the Affimer technology Wetherby and Cambridge, UK, 10 October 2018: Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has agreed a commercial license with New England Biolabs® (NEB®) (Ipswich MA, USA), a global leader in the discovery and production of enzymes […]

Cambridge, UK – Abcam’s new phosphate buffered saline (PBS)-only recombinant antibodies are free from preservatives and stabilising agents, offering improved flexibility for researchers conducting more complex experiments. Typically, antibodies are stored in a buffer composed of bovine serum albumin (BSA), glycerol and sodium azide to ensure stability. However, these components can inhibit effective conjugation to certain […]

DSP to be Applied to Transplant Research of Regulatory T Cell Therapy in Kidney Transplantation SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the University of Oxford has been selected as the winning recipient of a grant for a GeoMx™ Digital Spatial Profiler (DSP) […]

PUROLITE READY TO LOWER THE COST OF PROTEIN A, WITH OPENING OF 100,000L-CAPACITY UK AGAROSE MANUFACTURING FACILITY IN WALES, UK Purolite Life Sciences, a leading manufacturer and distributor of agarose resins to the biopharmaceutical industry, today announces the opening of a state-of-the-art agarose resin manufacturing facility. Capable of producing 100,000L annually – equating to 30% […]

Experimental data from ambr15 and ambr250 bioreactors are now directly captured and integrated into the Genedata Bioprocess workflow management system Basel, Switzerland Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced a new out-of-the-box integration of the Genedata Bioprocess® platform with the ambr® mini-bioreactor systems from Sartorius, a leading international pharmaceutical and laboratory equipment […]

Novus Biologicals and R&D Systems announce that they will list their catalog of antibodies on BenchSci’s website to increase the amount of published antibody validation data available to researchers. BenchSci is a revolutionary data mining company that uses artificial intelligence and machine learning to gather published antibody usage data from open- and closed-access journals about […]

DANVERS, MA (PRWEB) – Cell Signaling Technology (CST) a leading provider of antibodies, kits, and services, announced that Genentech, a member of the Roche Group, has licensed proprietary PTMScan® technology from CST, further enabling discovery proteomics research. The CST PTMScan technology is an immuno-affinity enrichment method that allows for the discovery of hundreds to thousands of […]

MINNEAPOLIS — Bio-Techne, a global leader of research and manufacturing-grade reagents, has announced a corporate initiative to advance cell and gene therapy research and ex vivo cell processing. Through strategic acquisitions and internal scientific innovation, Bio-Techne has become uniquely positioned to provide a comprehensive, innovative, and flexible set of reagents and instrumentation across the cell and gene […]

Phase II grant to support development of innovative exosome characterization platform BOSTON — NanoView Biosciences, an emerging leader in the field of exosome characterization, has been awarded a National Science Foundation Small Business Innovation Research Phase II grant in the amount of $750,000. The program will focus on completing development of the ExoView™ system, the company’s innovative instrument and […]